A lower percentage of the COVID cohort cases had neoadjuvant chemoradiotherapy (19 vs 30%), but this did not reach statistical significance.
← all excerpts
Maintaining Standards in Colorectal Cancer Surgery During the Global Pandemic: A Cohort Study.
1
—
—